These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 25305077)

  • 1. OCRL-mutated fibroblasts from patients with Dent-2 disease exhibit INPP5B-independent phenotypic variability relatively to Lowe syndrome cells.
    Montjean R; Aoidi R; Desbois P; Rucci J; Trichet M; Salomon R; Rendu J; Fauré J; Lunardi J; Gacon G; Billuart P; Dorseuil O
    Hum Mol Genet; 2015 Feb; 24(4):994-1006. PubMed ID: 25305077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OCRL deficiency impairs endolysosomal function in a humanized mouse model for Lowe syndrome and Dent disease.
    Festa BP; Berquez M; Gassama A; Amrein I; Ismail HM; Samardzija M; Staiano L; Luciani A; Grimm C; Nussbaum RL; De Matteis MA; Dorchies OM; Scapozza L; Wolfer DP; Devuyst O
    Hum Mol Genet; 2019 Jun; 28(12):1931-1946. PubMed ID: 30590522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Characterization and Rescue of a Deep Intronic Mutation in OCRL Gene Responsible for Lowe Syndrome.
    Rendu J; Montjean R; Coutton C; Suri M; Chicanne G; Petiot A; Brocard J; Grunwald D; Pietri Rouxel F; Payrastre B; Lunardi J; Dorseuil O; Marty I; Fauré J
    Hum Mutat; 2017 Feb; 38(2):152-159. PubMed ID: 27790796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype Phenotype Correlation in Dent Disease 2 and Review of the Literature:
    Gianesello L; Arroyo J; Del Prete D; Priante G; Ceol M; Harris PC; Lieske JC; Anglani F
    Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34680992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of OCRL increases ciliary PI(4,5)P
    Prosseda PP; Luo N; Wang B; Alvarado JA; Hu Y; Sun Y
    J Cell Sci; 2017 Oct; 130(20):3447-3454. PubMed ID: 28871046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney Tubular Ablation of
    Inoue K; Balkin DM; Liu L; Nandez R; Wu Y; Tian X; Wang T; Nussbaum R; De Camilli P; Ishibe S
    J Am Soc Nephrol; 2017 May; 28(5):1399-1407. PubMed ID: 27895154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2.
    De Matteis MA; Staiano L; Emma F; Devuyst O
    Nat Rev Nephrol; 2017 Aug; 13(8):455-470. PubMed ID: 28669993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cellular and physiological functions of the Lowe syndrome protein OCRL1.
    Mehta ZB; Pietka G; Lowe M
    Traffic; 2014 May; 15(5):471-87. PubMed ID: 24499450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onset mechanism of a female patient with Dent disease 2.
    Okamoto T; Sakakibara N; Nozu K; Takahashi T; Hayashi A; Sato Y; Nagano C; Matsuo M; Iijima K; Manabe A
    Clin Exp Nephrol; 2020 Oct; 24(10):946-954. PubMed ID: 32666344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 3D Renal Proximal Tubule on Chip Model Phenocopies Lowe Syndrome and Dent II Disease Tubulopathy.
    Naik S; Wood AR; Ongenaert M; Saidiyan P; Elstak ED; Lanz HL; Stallen J; Janssen R; Smythe E; Erdmann KS
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OCRL localizes to the primary cilium: a new role for cilia in Lowe syndrome.
    Luo N; West CC; Murga-Zamalloa CA; Sun L; Anderson RM; Wells CD; Weinreb RN; Travers JB; Khanna H; Sun Y
    Hum Mol Genet; 2012 Aug; 21(15):3333-44. PubMed ID: 22543976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel OCRL isoforms associated with phenotypic differences between Dent disease-2 and Lowe syndrome.
    Sakakibara N; Ijuin T; Horinouchi T; Yamamura T; Nagano C; Okada E; Ishiko S; Aoto Y; Rossanti R; Ninchoji T; Awano H; Nagase H; Minamikawa S; Tanaka R; Matsuyama T; Nagatani K; Kamei K; Jinnouchi K; Ohtsuka Y; Oka M; Araki Y; Tanaka T; Harada MS; Igarashi T; Kitahara H; Morisada N; Nakamura SI; Okada T; Iijima K; Nozu K
    Nephrol Dial Transplant; 2022 Jan; 37(2):262-270. PubMed ID: 34586410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Base editing correction of OCRL in Lowe syndrome: ABE-mediated functional rescue in patient-derived fibroblasts.
    Chen S; Lo CH; Liu Z; Wang Q; Ning K; Li T; Sun Y
    Hum Mol Genet; 2024 Jun; 33(13):1142-1151. PubMed ID: 38557732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse model for Lowe syndrome/Dent Disease 2 renal tubulopathy.
    Bothwell SP; Chan E; Bernardini IM; Kuo YM; Gahl WA; Nussbaum RL
    J Am Soc Nephrol; 2011 Mar; 22(3):443-8. PubMed ID: 21183592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the neuropsychiatric manifestations of Lowe syndrome using induced pluripotent stem cells: defective F-actin polymerization and WAVE-1 expression in neuronal cells.
    Barnes J; Salas F; Mokhtari R; Dolstra H; Pedrosa E; Lachman HM
    Mol Autism; 2018; 9():44. PubMed ID: 30147856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compensatory Role of Inositol 5-Phosphatase INPP5B to OCRL in Primary Cilia Formation in Oculocerebrorenal Syndrome of Lowe.
    Luo N; Kumar A; Conwell M; Weinreb RN; Anderson R; Sun Y
    PLoS One; 2013; 8(6):e66727. PubMed ID: 23805271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species-specific difference in expression and splice-site choice in Inpp5b, an inositol polyphosphate 5-phosphatase paralogous to the enzyme deficient in Lowe Syndrome.
    Bothwell SP; Farber LW; Hoagland A; Nussbaum RL
    Mamm Genome; 2010 Oct; 21(9-10):458-66. PubMed ID: 20872266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The phosphoinositide 3-kinase inhibitor alpelisib restores actin organization and improves proximal tubule dysfunction in vitro and in a mouse model of Lowe syndrome and Dent disease.
    Berquez M; Gadsby JR; Festa BP; Butler R; Jackson SP; Berno V; Luciani A; Devuyst O; Gallop JL
    Kidney Int; 2020 Oct; 98(4):883-896. PubMed ID: 32919786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of intestinal calcium entry channel TRPV6 by OCRL, a lipid phosphatase associated with Lowe syndrome and Dent disease.
    Wu G; Zhang W; Na T; Jing H; Wu H; Peng JB
    Am J Physiol Cell Physiol; 2012 May; 302(10):C1479-91. PubMed ID: 22378746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incomplete cryptic splicing by an intronic mutation of OCRL in patients with partial phenotypes of Lowe syndrome.
    Nakano E; Yoshida A; Miyama Y; Yabuuchi T; Kajiho Y; Kanda S; Miura K; Oka A; Harita Y
    J Hum Genet; 2020 Oct; 65(10):831-839. PubMed ID: 32427950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.